Original Contributions |
From the Institute of Experimental and Clinical Research (H.B.R., U.M., M.C., S.J., L.B.-S.), Aarhus University, and the Department of Anaesthesiology (H.B.R., M.C., L.J.), the Department of Cardiology (U.M.), and the Department of Thoracic and Cardiovascular Surgery (L.B.I., V.E.H.) Aarhus University Hospital, Aarhus, Denmark; and the Department of Cardiology (C.I.O.B, P.W.), Royal Brompton Hospital, London, UK.
Correspondence to Hanne B. Ravn, MD, PhD, Institute of Experimental and Clinical Research, Skejby Hospital, DK-8200 Aarhus N, Denmark. E-mail hbr{at}iekf.aau.dk
AbstractExperimental studies have demonstrated that intravenous magnesium (Mg) can protect the ischemic myocardium and has an antithrombotic effect. In patients with myocardial infarction, the reperfusion injury is complicated by the presence of a thrombogenic area in the affected coronary artery that may cause repetitive thrombus formation and embolization. We investigated the effect of Mg on infarct size in a randomized study in pigs. Myocardial infarction was induced by a 50-minute mechanical occlusion of the left anterior descending artery combined with an arterial injury, which stimulated a dynamic thrombus formation with emboli shedding on reperfusion. Magnesium sulfate (6 mmol/20 min plus 3 mmol/h) or saline was started at 30 minutes after coronary occlusion. Real-time ventricular pressurevolume loops were generated from the left ventricle by using a microtip pressure manometer and a conductance catheter. Platelet accumulation in the myocardium was evaluated by using 111In-labeled platelets. After 4 hours of reperfusion, the infarct size/area at risk ratio in the placebo group was 46±0.06% (n=8) compared with 22±0.07% (n=6) in the Mg-treated animals (P=0.03). Ejection fraction decreased significantly in the control group but not in the Mg-treated animals (P=0.03). Platelet accumulation in the myocardium did not change significantly between the Mg- and placebo-treated animals (placebo group, 191±19%; Mg group, 177±29%; NS). The present study demonstrates that intravenous Mg infusion is able to reduce infarct size by >50% and preserve the ejection fraction in this model where ischemia/reperfusion injury was evaluated in the presence of a thrombogenic area in the nutrient artery.
Key Words: magnesium animals reperfusion injury thrombosis platelets
This article has been cited by other articles:
![]() |
J. Amighi, S. Sabeti, O. Schlager, W. Mlekusch, M. Exner, W. Lalouschek, R. Ahmadi, E. Minar, and M. Schillinger Low Serum Magnesium Predicts Neurological Events in Patients With Advanced Atherosclerosis Stroke, January 1, 2004; 35(1): 22 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pye, F. Ardeshirpour, A. McCain, D. A. Bellinger, E. Merricks, J. Adams, P. J. Elliott, C. Pien, T. H. Fischer, A. S. Baldwin Jr., et al. Proteasome inhibition ablates activation of NF-kappa B in myocardial reperfusion and reduces reperfusion injury Am J Physiol Heart Circ Physiol, March 1, 2003; 284(3): H919 - H926. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Woods Commentary: Biostatistics, biological mechanisms and Bayes: lessons from the magnesium trials Int. J. Epidemiol., February 1, 2002; 31(1): 105 - 106. [Full Text] [PDF] |
||||
![]() |
V. Rukshin, B. Azarbal, P. K. Shah, V. T. Tsang, M. Shechter, A. Finkelstein, B. Cercek, and S. Kaul Intravenous Magnesium in Experimental Stent Thrombosis in Swine Arterioscler Thromb Vasc Biol, September 1, 2001; 21(9): 1544 - 1549. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |